Clinical Trials Browser

Locally Advanced Cervical Cancer

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

Glioblastoma

Sarcoma, Kaposi

Carcinoma, Transitional Cell

Carcinoma, Non-Small-Cell Lung

Prostatic Neoplasms

Recurrence, Lymphoma, T-Cell, Cutaneous

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Stomach Neoplasms

Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Neoplasms

Genital Neoplasms, Male, Neoplasms by Site, Prostatic Neoplasms, Urogenital Neoplasms

Fatigue, Neoplasms, Second Primary

Hand-Foot Skin Reaction (HFSR)

Bladder Urothelial Cancer

Carcinoma, Hepatocellular

Muscle Invasive Bladder Carcinoma

Lymphoma, Large B-Cell, Diffuse

Carcinoma, Uterine Cervical Dysplasia, Neoplasms, Neoplasms, Glandular and Epithelial

Kidney Neoplasms

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck

Biliary Tract Neoplasms

Gynecological Malignancy

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, Large B-Cell, Diffuse

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Lymphoma, Mantle-Cell

Differentiated Thyroid Cancer

Arrhythmias, Cardiac, Heart Failure, Neoplasms

Colorectal Neoplasms

Recurrence, Lymphoma, Large B-Cell, Diffuse

Leiomyosarcoma

Carcinoma, Carcinoma, Basal Cell

EGFRI Induced Acneiform Lesions

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Sarcoma, Kaposi, Carcinoma, Merkel Cell

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Xeroderma Pigmentosum

Breast Neoplasms

Colorectal Neoplasms

Carcinoma, Hepatocellular

Breast Cancer Metastatic

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms, Carcinoma, Renal Cell, Triple Negative Breast Neoplasms

Head and Neck Neoplasms, Mucositis

Colorectal Neoplasms, Mucositis

Squamous Cell Carcinoma of Head and Neck

Clinical Trials

A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma

TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.

A Study of sEphB4-HSA in Kaposi Sarcoma

A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma

KICKSTART

LUCIDA_2

Mogamulizumab Q4week Dosing in Participants With R/R CTCL

Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)

Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancer

Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors

A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts

The Safety and Efficacy of Redsenol-1 Plus on Cancer-related Fatigue in Adults

NOVA-II

An Efficacy and Safety Study of ICP-192 in Subjects With Bladder Urothelial Cancer

GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma

A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression)

A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer

Mitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions

A Study of HB0025 Injection in Patients With Advanced Renal Cancer

A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC

A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer

A Study of RC48-ADC for the Treatment of HER2-expressing Gynecological Malignancies

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer

A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC)

Evaluating Different Doses of Orelabrutinib in MCL

DTC

A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients

A Study of JMT101 in Patients With Metastatic Colorectal Cancer

Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects

FIBROSARC US

DUNCAN

LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC

IntriNSiC

Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer

Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer

A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V

A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer

Phase 2 Study of CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With Relapsed and/or Refractory Metastatic Colorectal Cancer

OASES

A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC

The Efficacy of HLX208 (BRAF V600E Inhibitor) With Cetuximab for Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation After First-line Treatment

X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib

MARIO-3

Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690

Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690

Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors